hims glp-1 vs ozempic & Hers swings to a loss in Q1 amid shift in strategy Hims & Hers set for

While long-term clinical studies are ongoing, we can be carefully optimistic that improved GLP-1-based pharmacology can one day be safely applied to further lower body weight relative to currently available GLP-1R agonists

Morgan (2023)

For postpartum women with insulin resistance, PCOS, or gestational diabetes that persists after delivery, metformin may serve double duty by managing blood sugar and supporting weight loss

Patients often experience increased energy levels, better mood, and enhanced physical mobility, contributing to a more active and fulfilling lifestyle

P., Auerbach, P., Bajaj, H

Suresh Ramalingam, executive director of Winship Cancer Institute of Emory University and the trials principal investigator, called the approval a major breakthrough for this patient group